Revolution in Medicine – BioNTech, mRNA and the Covid-19 Vaccine
BioNTech was founded by scientists Uğur Şahin and Özlem Türeci to create individualised cancer treatments using mRNA. This DW Documentary tells how that work became the Covid-19 vaccine, after the company pivoted in January 2020 when a new virus was identified in Wuhan, China.
The film follows the research, the funding and the partnership with Pfizer that led to the approval of the Comirnaty vaccine. It also looks ahead, to what mRNA technology might do next in cancer research and in preventing malaria.
Key Themes & Topics Examined
- mRNA technology in vaccine development
- The founding of BioNTech
- Developing the Covid-19 vaccine
- The role of Uğur Şahin and Özlem Türeci
- The funding and logistics of pharmaceutical research
- Future uses of mRNA in medicine
Archival & Investigative Sources
- Interviews with BioNTech founders Uğur Şahin and Özlem Türeci
- Coverage of the vaccine development timeline
- Information on financial backers and partnerships
- Analysis of mRNA technology’s scientific principles
Recommended Companion Viewing
Explore authoritative investigative documentaries on related historical events and investigative subjects.
Can Humans Sense Magnetic Fields?
The International Space Station: A Unique Space Project
The Biggest Chemical Coverup In History
Frequently Asked Questions
What is mRNA technology?
mRNA, or messenger ribonucleic acid, delivers genetic information to cells, instructing them to produce specific proteins. In the context of vaccines, this process enables the body to produce antigens that trigger an immune response against a virus.
Who founded BioNTech?
BioNTech was founded by scientists Uğur Şahin and Özlem Türeci.
What was BioNTech’s initial research focus?
BioNTech’s initial research focus was on developing individualized cancer treatments using mRNA technology.
How did BioNTech develop the COVID-19 vaccine?
BioNTech utilized its existing mRNA technology platform to develop a COVID-19 vaccine, accelerating the process through significant funding and a partnership with Pfizer for testing and distribution.


